Register entry

Qilu Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
5
Active NDC listings
57
Labeller names
3
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Analytical testing5Active ingredient (API) manufacture3Labelling4Finished drug manufacture2Packaging4
Sites

Registered establishments

5
EstablishmentAddressRegistered forFEI / DUNS
Qilu Pharmaceutical Co., Ltd. (Laoling Site)Registrant: Qilu Pharmaceutical Co., Ltd.Circular Economy Demonstration Park, Laoling County, Dezhou, Shandong 253600, China (CHN)Analytical testing, Active ingredient (API) manufacture3026771716699440617
Qilu Pharmaceutical Co., Ltd.No.23999, Gong Ye Bei Road, Jinan, Shandong 250100, China (CHN)Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging3003674637653878256
Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park)Registrant: Qilu Pharmaceutical Co., Ltd.8888 Lvyou Road, High-tech Zone, Jinan, Shandong 250104, China (CHN)Analytical testing, Labelling, Finished drug manufacture, Packaging3014576629544532200
Qilu Pharmaceutical Co., Ltd. (Dongjia Site)Registrant: Qilu Pharmaceutical Co., Ltd.No. 849, Dongjia Town, Licheng District, Jinan, Shandong 250105, China (CHN)Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging3021324493699432206
Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site)Registrant: Qilu Pharmaceutical Co., Ltd.No.317, Xinluo Road, High-tech Zone, Jinan, Shandong 250101, China (CHN)Analytical testing, Labelling, Finished drug manufacture, Packaging3003802432421279342
Catalogue

Drug listings by form and route

57

57 active NDC listings: 54 human prescription drug, 3 bulk ingredient. By marketing category: ANDA 54, BULK INGREDIENT 3.

Dosage formNDCs
injection, solution11
injection, powder, lyophilized, for solution10
injection, powder, for solution9
tablet8
tablet, film coated5
injection4
powder3
capsule2
kit2
tablet, film coated, extended release2
tablet, coated1
RouteNDCs
intravenous33
oral18
intramuscular13
subcutaneous3
Labeller name on the listingNDCs
qilu pharmaceutical co., ltd.52
qilu pharmaceutical co. ltd.3
qilu pharmaceutical co., ltd2
Catalogue

Marketed products

57
BrandGeneric nameForm / routeNDC
Amikacin SulfateAmikacin Sulfateinjection, solution, intramuscular, intravenous67184-0569ANDA
Amikacin SulfateAmikacin Sulfateinjection, solution, intramuscular, intravenous67184-0570ANDA
-Bortezomibpowder67184-0026BULK INGREDIENT
BortezomibBortezomibinjection, powder, lyophilized, for solution, intravenous, subcutaneous67184-0530ANDA
BumetanideBumetanideinjection, intramuscular, intravenous67184-0593ANDA
BumetanideBumetanideinjection, intramuscular, intravenous67184-0594ANDA
CefazolinCefazolininjection, powder, for solution, intramuscular, intravenous67184-1001ANDA
CefepimeCEFEPIME HYDROCHLORIDEinjection, powder, for solution, intramuscular, intravenous67184-1002ANDA
CefepimeCEFEPIME HYDROCHLORIDEinjection, powder, for solution, intramuscular, intravenous67184-1003ANDA
CefepimeCEFEPIME HYDROCHLORIDEinjection, powder, for solution, intravenous67184-1004ANDA
Ceftriaxone SodiumCeftriaxone Sodiuminjection, powder, for solution, intramuscular, intravenous67184-1005ANDA
Ceftriaxone SodiumCeftriaxone Sodiuminjection, powder, for solution, intramuscular, intravenous67184-1006ANDA
Ceftriaxone SodiumCeftriaxone Sodiuminjection, powder, for solution, intramuscular, intravenous67184-1007ANDA
Ceftriaxone SodiumCeftriaxone Sodiuminjection, powder, for solution, intramuscular, intravenous67184-1008ANDA
Cetrorelix acetateCetrorelix Acetate for Injectionkit, subcutaneous67184-0605ANDA
DaptomycinDaptomycininjection, powder, lyophilized, for solution, intravenous67184-0549ANDA
Decitabinedecitabineinjection, powder, lyophilized, for solution, intravenous67184-0535ANDA
FOSAPREPITANT DIMEGLUMINEFOSAPREPITANT DIMEGLUMINEinjection, powder, lyophilized, for solution, intravenous67184-0540ANDA
Ganirelix AcetateGanirelix Acetateinjection, solution, subcutaneous67184-0574ANDA
GefitinibGefitinibtablet, coated, oral67184-0531ANDA
HYDROXYUREAHYDROXYUREAcapsule, oral67184-0607ANDA
Icosapent EthylIcosapent Ethylcapsule, oral67184-0582ANDA
Irinotecan HydrochlorideIrinotecan Hydrochlorideinjection, solution, intravenous67184-0511ANDA
Irinotecan HydrochlorideIrinotecan Hydrochlorideinjection, solution, intravenous67184-0512ANDA
Irinotecan HydrochlorideIrinotecan Hydrochlorideinjection, solution, intravenous67184-0513ANDA
MICAFUNGINMicafungininjection, powder, lyophilized, for solution, intravenous67184-0589ANDA
MICAFUNGINMicafungininjection, powder, lyophilized, for solution, intravenous67184-0590ANDA
Melphalan Hydrochloridemelphalan hydrochloridekit, intravenous67184-0618ANDA
Mirabegronmirabegrontablet, film coated, extended release, oral67184-0571ANDA
Mirabgeornmirabegrontablet, film coated, extended release, oral67184-0572ANDA
Nicardipine HydrochlorideNicardipine Hydrochlorideinjection, solution, intravenous67184-0611ANDA
ONDANSETRONONDANSETRONinjection, solution, intramuscular, intravenous67184-0507ANDA
OlanzapineOlanzapinetablet, oral67184-0561ANDA
OlanzapineOlanzapinetablet, oral67184-0562ANDA
OlanzapineOlanzapinetablet, oral67184-0563ANDA
OlanzapineOlanzapinetablet, oral67184-0564ANDA
OlanzapineOlanzapinetablet, oral67184-0565ANDA
OlanzapineOlanzapinetablet, oral67184-0566ANDA
OlanzapineOlanzapineinjection, powder, for solution, intramuscular67184-0573ANDA
-Oxaliplatinpowder67184-0007BULK INGREDIENT
OxaliplatinOxaliplatininjection, powder, lyophilized, for solution, intravenous67184-0501ANDA
OxaliplatinOxaliplatininjection, powder, lyophilized, for solution, intravenous67184-0502ANDA
Oxaliplatinoxaliplatininjection, solution, intravenous67184-0508ANDA
Oxaliplatinoxaliplatininjection, solution, intravenous67184-0509ANDA
OxaliplatinOxaliplatininjection, solution, intravenous67184-0510ANDA
PalonosetronPalonosetron Hydrochlorideinjection, intravenous67184-0514ANDA
PalonosetronPalonosetron Hydrochlorideinjection, intravenous67184-0515ANDA
-Palonosetron Hydrochloridepowder67184-0013BULK INGREDIENT
PemetrexedPemetrexed disodiuminjection, powder, lyophilized, for solution, intravenous67184-0503ANDA
PemetrexedPemetrexed disodiuminjection, powder, lyophilized, for solution, intravenous67184-0504ANDA
Solifenacin SuccinateSolifenacin Succinate Tabletstablet, film coated, oral67184-0517ANDA
TadalafilTadalafiltablet, film coated, oral67184-0523ANDA
TadalafilTadalafiltablet, film coated, oral67184-0524ANDA
TadalafilTadalafiltablet, film coated, oral67184-0525ANDA
TadalafilTadalafiltablet, film coated, oral67184-0526ANDA
imatinib mesylateimatinib mesylatetablet, oral67184-0532ANDA
imatinib mesylateimatinib mesylatetablet, oral67184-0533ANDA
Neighbours

Registered in the same town

7
Compare

Comparable companies in China

Enquiry

Common questions

Is Qilu Pharmaceutical Co., Ltd. FDA approved?
Qilu Pharmaceutical Co., Ltd. holds 5 FDA-registered establishments in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Qilu Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Dezhou; Jinan. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does Qilu Pharmaceutical Co., Ltd. make?
57 products are listed under Qilu Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as injection, solution; injection, powder, lyophilized, for solution; injection, powder, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.